Gsa Capital Partners LLP Gossamer Bio, Inc. Transaction History

Gsa Capital Partners LLP

$1.43 Billion
Q2 2025

A detailed history of Gsa Capital Partners LLP transactions in Gossamer Bio, Inc. stock. As of the latest transaction made, Gsa Capital Partners LLP holds 760,448 shares of GOSS stock, worth $1.76 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

760,448

Previous 695,553 9.33%

Holding current value

$1.76 Million

Previous $765,000 22.22%

% of portfolio

0.07%

Previous 0.07%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 22, 2025	BUY	$0.78 - $1.44 $50,618 - $93,448	64,895 Added 9.33%	760,448 $935,000
Q1 2025 May 08, 2025	SELL	$0.85 - $1.53 $141,831 - $255,295	-166,860 Reduced 19.35%	695,553 $765,000
Q4 2024 Feb 07, 2025	BUY	$0.66 - $1.07 $524,612 - $850,507	794,867 Added 1176.78%	862,413 $780,000
Q3 2024 Nov 05, 2024	BUY	$0.79 - $1.25 $53,361 - $84,432	67,546 New	67,546 $67,000
Q2 2023 Aug 14, 2023	BUY	$0.98 - $1.53 $450,159 - $702,799	459,346 Added 1803.05%	484,822 $581,000
Q1 2023 May 12, 2023	SELL	$0.96 - $2.92 $96,980 - $294,981	-101,021 Reduced 79.86%	25,476 $32,000
Q4 2022 Feb 13, 2023	BUY	$1.74 - $12.87 $148,296 - $1.1 Million	85,228 Added 206.52%	126,497 $274,000
Q3 2022 Nov 14, 2022	BUY	$7.21 - $14.88 $140,212 - $289,371	19,447 Added 89.12%	41,269 $494,000
Q2 2022 Aug 09, 2022	BUY	$5.97 - $9.97 $12,626 - $21,086	2,115 Added 10.73%	21,822 $183,000
Q1 2022 May 11, 2022	BUY	$8.44 - $12.49 $166,327 - $246,140	19,707 New	19,707 $171,000
Q4 2021 Feb 14, 2022	SELL	$10.12 - $14.07 $107,049 - $148,832	-10,578 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$7.25 - $13.23 $76,690 - $139,946	10,578 New	10,578 $133,000
Q2 2021 Aug 05, 2021	SELL	$8.0 - $9.75 $308,048 - $375,433	-38,506 Closed	0 $0
Q1 2021 May 10, 2021	BUY	$8.63 - $10.94 $332,306 - $421,255	38,506 New	38,506 $356,000
Q4 2020 Feb 03, 2021	SELL	$8.3 - $13.59 $526,726 - $862,434	-63,461 Closed	0 $0
Q3 2020 Nov 06, 2020	BUY	$11.3 - $14.75 $558,762 - $729,358	49,448 Added 352.87%	63,461 $788,000
Q2 2020 Aug 11, 2020	SELL	$9.52 - $15.98 $210,277 - $352,966	-22,088 Reduced 61.18%	14,013 $182,000
Q1 2020 May 12, 2020	BUY	$8.0 - $15.48 $288,808 - $558,843	36,101 New	36,101 $366,000

Others Institutions Holding GOSS

# of Institutions

139

Shares Held

159M

Call Options Held

2.89M

Put Options Held

130K

View Full List

About Gossamer Bio, Inc.

Ticker GOSS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,954,000
Market Cap $217M
Description
Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...

More about GOSS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Gsa Capital Partners LLP with notifications on news.

Account

Gsa Capital Partners LLP Gossamer Bio, Inc. Transaction History